nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—CYP1A2—Dacarbazine—pancreatic cancer	0.0778	0.327	CbGbCtD
Zolmitriptan—CYP1A2—Tamoxifen—pancreatic cancer	0.0619	0.26	CbGbCtD
Zolmitriptan—CYP1A2—Erlotinib—pancreatic cancer	0.0526	0.221	CbGbCtD
Zolmitriptan—CYP1A2—Fluorouracil—pancreatic cancer	0.0456	0.192	CbGbCtD
Zolmitriptan—Leukopenia—Docetaxel—pancreatic cancer	0.00034	0.000591	CcSEcCtD
Zolmitriptan—Pollakiuria—Epirubicin—pancreatic cancer	0.00034	0.00059	CcSEcCtD
Zolmitriptan—Body temperature increased—Fluorouracil—pancreatic cancer	0.000339	0.00059	CcSEcCtD
Zolmitriptan—Eosinophilia—Doxorubicin—pancreatic cancer	0.000337	0.000586	CcSEcCtD
Zolmitriptan—Palpitations—Docetaxel—pancreatic cancer	0.000336	0.000584	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000335	0.000583	CcSEcCtD
Zolmitriptan—Weight increased—Epirubicin—pancreatic cancer	0.000334	0.000582	CcSEcCtD
Zolmitriptan—Loss of consciousness—Docetaxel—pancreatic cancer	0.000334	0.00058	CcSEcCtD
Zolmitriptan—Pancreatitis—Doxorubicin—pancreatic cancer	0.000333	0.00058	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000332	0.000577	CcSEcCtD
Zolmitriptan—Cough—Docetaxel—pancreatic cancer	0.000331	0.000576	CcSEcCtD
Zolmitriptan—Angina pectoris—Doxorubicin—pancreatic cancer	0.000331	0.000576	CcSEcCtD
Zolmitriptan—Hypersensitivity—Irinotecan—pancreatic cancer	0.00033	0.000574	CcSEcCtD
Zolmitriptan—Pneumonia—Epirubicin—pancreatic cancer	0.00033	0.000573	CcSEcCtD
Zolmitriptan—Convulsion—Docetaxel—pancreatic cancer	0.000329	0.000572	CcSEcCtD
Zolmitriptan—Hypertension—Docetaxel—pancreatic cancer	0.000328	0.00057	CcSEcCtD
Zolmitriptan—Bronchitis—Doxorubicin—pancreatic cancer	0.000327	0.000569	CcSEcCtD
Zolmitriptan—Arthralgia—Docetaxel—pancreatic cancer	0.000323	0.000562	CcSEcCtD
Zolmitriptan—Chest pain—Docetaxel—pancreatic cancer	0.000323	0.000562	CcSEcCtD
Zolmitriptan—Myalgia—Docetaxel—pancreatic cancer	0.000323	0.000562	CcSEcCtD
Zolmitriptan—Nausea—Sunitinib—pancreatic cancer	0.000323	0.000562	CcSEcCtD
Zolmitriptan—Asthenia—Irinotecan—pancreatic cancer	0.000322	0.000559	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000321	0.000559	CcSEcCtD
Zolmitriptan—Stomatitis—Epirubicin—pancreatic cancer	0.000319	0.000556	CcSEcCtD
Zolmitriptan—Jaundice—Epirubicin—pancreatic cancer	0.000319	0.000556	CcSEcCtD
Zolmitriptan—Urinary tract infection—Epirubicin—pancreatic cancer	0.000319	0.000554	CcSEcCtD
Zolmitriptan—Conjunctivitis—Epirubicin—pancreatic cancer	0.000319	0.000554	CcSEcCtD
Zolmitriptan—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000316	0.00055	CcSEcCtD
Zolmitriptan—Dry mouth—Docetaxel—pancreatic cancer	0.000316	0.00055	CcSEcCtD
Zolmitriptan—Sweating—Epirubicin—pancreatic cancer	0.000314	0.000546	CcSEcCtD
Zolmitriptan—Pollakiuria—Doxorubicin—pancreatic cancer	0.000314	0.000546	CcSEcCtD
Zolmitriptan—Asthenia—Gemcitabine—pancreatic cancer	0.000313	0.000545	CcSEcCtD
Zolmitriptan—Haematuria—Epirubicin—pancreatic cancer	0.000312	0.000543	CcSEcCtD
Zolmitriptan—Confusional state—Docetaxel—pancreatic cancer	0.000312	0.000543	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00031	0.00054	CcSEcCtD
Zolmitriptan—Oedema—Docetaxel—pancreatic cancer	0.00031	0.000539	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00031	0.000539	CcSEcCtD
Zolmitriptan—Weight increased—Doxorubicin—pancreatic cancer	0.000309	0.000538	CcSEcCtD
Zolmitriptan—Epistaxis—Epirubicin—pancreatic cancer	0.000309	0.000538	CcSEcCtD
Zolmitriptan—Pruritus—Gemcitabine—pancreatic cancer	0.000309	0.000537	CcSEcCtD
Zolmitriptan—Infection—Docetaxel—pancreatic cancer	0.000308	0.000535	CcSEcCtD
Zolmitriptan—Sinusitis—Epirubicin—pancreatic cancer	0.000307	0.000535	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000307	0.000534	CcSEcCtD
Zolmitriptan—Diarrhoea—Irinotecan—pancreatic cancer	0.000307	0.000533	CcSEcCtD
Zolmitriptan—Pneumonia—Doxorubicin—pancreatic cancer	0.000305	0.00053	CcSEcCtD
Zolmitriptan—Shock—Docetaxel—pancreatic cancer	0.000305	0.00053	CcSEcCtD
Zolmitriptan—Nervous system disorder—Docetaxel—pancreatic cancer	0.000304	0.000529	CcSEcCtD
Zolmitriptan—Pruritus—Fluorouracil—pancreatic cancer	0.000304	0.000528	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000303	0.000528	CcSEcCtD
Zolmitriptan—Tachycardia—Docetaxel—pancreatic cancer	0.000302	0.000526	CcSEcCtD
Zolmitriptan—Skin disorder—Docetaxel—pancreatic cancer	0.000301	0.000523	CcSEcCtD
Zolmitriptan—Bradycardia—Epirubicin—pancreatic cancer	0.000299	0.000521	CcSEcCtD
Zolmitriptan—Diarrhoea—Gemcitabine—pancreatic cancer	0.000299	0.00052	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000297	0.000517	CcSEcCtD
Zolmitriptan—Dizziness—Irinotecan—pancreatic cancer	0.000296	0.000516	CcSEcCtD
Zolmitriptan—Jaundice—Doxorubicin—pancreatic cancer	0.000296	0.000514	CcSEcCtD
Zolmitriptan—Stomatitis—Doxorubicin—pancreatic cancer	0.000296	0.000514	CcSEcCtD
Zolmitriptan—Anorexia—Docetaxel—pancreatic cancer	0.000295	0.000514	CcSEcCtD
Zolmitriptan—Rhinitis—Epirubicin—pancreatic cancer	0.000295	0.000513	CcSEcCtD
Zolmitriptan—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000295	0.000513	CcSEcCtD
Zolmitriptan—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000295	0.000513	CcSEcCtD
Zolmitriptan—Diarrhoea—Fluorouracil—pancreatic cancer	0.000294	0.000511	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000293	0.000509	CcSEcCtD
Zolmitriptan—Pharyngitis—Epirubicin—pancreatic cancer	0.000292	0.000508	CcSEcCtD
Zolmitriptan—Sweating—Doxorubicin—pancreatic cancer	0.000291	0.000506	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000291	0.000505	CcSEcCtD
Zolmitriptan—Oedema peripheral—Epirubicin—pancreatic cancer	0.00029	0.000504	CcSEcCtD
Zolmitriptan—Haematuria—Doxorubicin—pancreatic cancer	0.000289	0.000503	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000289	0.000503	CcSEcCtD
Zolmitriptan—Urethral disorder—Epirubicin—pancreatic cancer	0.000288	0.000502	CcSEcCtD
Zolmitriptan—Epistaxis—Doxorubicin—pancreatic cancer	0.000286	0.000497	CcSEcCtD
Zolmitriptan—Vomiting—Irinotecan—pancreatic cancer	0.000285	0.000496	CcSEcCtD
Zolmitriptan—Sinusitis—Doxorubicin—pancreatic cancer	0.000284	0.000495	CcSEcCtD
Zolmitriptan—Dizziness—Fluorouracil—pancreatic cancer	0.000284	0.000494	CcSEcCtD
Zolmitriptan—Rash—Irinotecan—pancreatic cancer	0.000283	0.000492	CcSEcCtD
Zolmitriptan—Dermatitis—Irinotecan—pancreatic cancer	0.000282	0.000491	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000282	0.000491	CcSEcCtD
Zolmitriptan—Headache—Irinotecan—pancreatic cancer	0.000281	0.000488	CcSEcCtD
Zolmitriptan—Insomnia—Docetaxel—pancreatic cancer	0.00028	0.000487	CcSEcCtD
Zolmitriptan—Paraesthesia—Docetaxel—pancreatic cancer	0.000278	0.000484	CcSEcCtD
Zolmitriptan—Vomiting—Gemcitabine—pancreatic cancer	0.000278	0.000483	CcSEcCtD
Zolmitriptan—Bradycardia—Doxorubicin—pancreatic cancer	0.000277	0.000482	CcSEcCtD
Zolmitriptan—Dyspnoea—Docetaxel—pancreatic cancer	0.000276	0.00048	CcSEcCtD
Zolmitriptan—Somnolence—Docetaxel—pancreatic cancer	0.000275	0.000479	CcSEcCtD
Zolmitriptan—Rash—Gemcitabine—pancreatic cancer	0.000275	0.000479	CcSEcCtD
Zolmitriptan—Dermatitis—Gemcitabine—pancreatic cancer	0.000275	0.000478	CcSEcCtD
Zolmitriptan—Tinnitus—Epirubicin—pancreatic cancer	0.000274	0.000477	CcSEcCtD
Zolmitriptan—Headache—Gemcitabine—pancreatic cancer	0.000274	0.000476	CcSEcCtD
Zolmitriptan—Cardiac disorder—Epirubicin—pancreatic cancer	0.000273	0.000475	CcSEcCtD
Zolmitriptan—Vomiting—Fluorouracil—pancreatic cancer	0.000273	0.000475	CcSEcCtD
Zolmitriptan—Rhinitis—Doxorubicin—pancreatic cancer	0.000273	0.000475	CcSEcCtD
Zolmitriptan—Dyspepsia—Docetaxel—pancreatic cancer	0.000273	0.000474	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000271	0.000471	CcSEcCtD
Zolmitriptan—Rash—Fluorouracil—pancreatic cancer	0.000271	0.000471	CcSEcCtD
Zolmitriptan—Dermatitis—Fluorouracil—pancreatic cancer	0.00027	0.00047	CcSEcCtD
Zolmitriptan—Pharyngitis—Doxorubicin—pancreatic cancer	0.00027	0.00047	CcSEcCtD
Zolmitriptan—Decreased appetite—Docetaxel—pancreatic cancer	0.000269	0.000468	CcSEcCtD
Zolmitriptan—Headache—Fluorouracil—pancreatic cancer	0.000269	0.000468	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000269	0.000468	CcSEcCtD
Zolmitriptan—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000268	0.000466	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000268	0.000465	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000267	0.000465	CcSEcCtD
Zolmitriptan—Angiopathy—Epirubicin—pancreatic cancer	0.000267	0.000464	CcSEcCtD
Zolmitriptan—Urethral disorder—Doxorubicin—pancreatic cancer	0.000267	0.000464	CcSEcCtD
Zolmitriptan—Nausea—Irinotecan—pancreatic cancer	0.000266	0.000463	CcSEcCtD
Zolmitriptan—Immune system disorder—Epirubicin—pancreatic cancer	0.000266	0.000462	CcSEcCtD
Zolmitriptan—Constipation—Docetaxel—pancreatic cancer	0.000265	0.000461	CcSEcCtD
Zolmitriptan—Pain—Docetaxel—pancreatic cancer	0.000265	0.000461	CcSEcCtD
Zolmitriptan—Chills—Epirubicin—pancreatic cancer	0.000264	0.000459	CcSEcCtD
Zolmitriptan—Arrhythmia—Epirubicin—pancreatic cancer	0.000263	0.000457	CcSEcCtD
Zolmitriptan—Nausea—Gemcitabine—pancreatic cancer	0.000259	0.000451	CcSEcCtD
Zolmitriptan—Erythema—Epirubicin—pancreatic cancer	0.000256	0.000445	CcSEcCtD
Zolmitriptan—Feeling abnormal—Docetaxel—pancreatic cancer	0.000255	0.000444	CcSEcCtD
Zolmitriptan—Nausea—Fluorouracil—pancreatic cancer	0.000255	0.000444	CcSEcCtD
Zolmitriptan—Tinnitus—Doxorubicin—pancreatic cancer	0.000254	0.000441	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000253	0.000441	CcSEcCtD
Zolmitriptan—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000253	0.000439	CcSEcCtD
Zolmitriptan—Tension—Epirubicin—pancreatic cancer	0.000251	0.000437	CcSEcCtD
Zolmitriptan—Dysgeusia—Epirubicin—pancreatic cancer	0.000251	0.000436	CcSEcCtD
Zolmitriptan—Nervousness—Epirubicin—pancreatic cancer	0.000249	0.000433	CcSEcCtD
Zolmitriptan—Back pain—Epirubicin—pancreatic cancer	0.000248	0.000431	CcSEcCtD
Zolmitriptan—Angiopathy—Doxorubicin—pancreatic cancer	0.000247	0.00043	CcSEcCtD
Zolmitriptan—Muscle spasms—Epirubicin—pancreatic cancer	0.000246	0.000428	CcSEcCtD
Zolmitriptan—Immune system disorder—Doxorubicin—pancreatic cancer	0.000246	0.000428	CcSEcCtD
Zolmitriptan—Abdominal pain—Docetaxel—pancreatic cancer	0.000245	0.000426	CcSEcCtD
Zolmitriptan—Body temperature increased—Docetaxel—pancreatic cancer	0.000245	0.000426	CcSEcCtD
Zolmitriptan—Chills—Doxorubicin—pancreatic cancer	0.000244	0.000425	CcSEcCtD
Zolmitriptan—Arrhythmia—Doxorubicin—pancreatic cancer	0.000243	0.000423	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000238	0.000413	CcSEcCtD
Zolmitriptan—Erythema—Doxorubicin—pancreatic cancer	0.000237	0.000412	CcSEcCtD
Zolmitriptan—Agitation—Epirubicin—pancreatic cancer	0.000235	0.000409	CcSEcCtD
Zolmitriptan—Tension—Doxorubicin—pancreatic cancer	0.000233	0.000404	CcSEcCtD
Zolmitriptan—Dysgeusia—Doxorubicin—pancreatic cancer	0.000232	0.000404	CcSEcCtD
Zolmitriptan—Malaise—Epirubicin—pancreatic cancer	0.000231	0.000402	CcSEcCtD
Zolmitriptan—Nervousness—Doxorubicin—pancreatic cancer	0.00023	0.0004	CcSEcCtD
Zolmitriptan—Vertigo—Epirubicin—pancreatic cancer	0.00023	0.0004	CcSEcCtD
Zolmitriptan—Syncope—Epirubicin—pancreatic cancer	0.00023	0.000399	CcSEcCtD
Zolmitriptan—Leukopenia—Epirubicin—pancreatic cancer	0.000229	0.000399	CcSEcCtD
Zolmitriptan—Back pain—Doxorubicin—pancreatic cancer	0.000229	0.000399	CcSEcCtD
Zolmitriptan—Hypersensitivity—Docetaxel—pancreatic cancer	0.000228	0.000397	CcSEcCtD
Zolmitriptan—Muscle spasms—Doxorubicin—pancreatic cancer	0.000228	0.000396	CcSEcCtD
Zolmitriptan—Palpitations—Epirubicin—pancreatic cancer	0.000226	0.000394	CcSEcCtD
Zolmitriptan—Loss of consciousness—Epirubicin—pancreatic cancer	0.000225	0.000391	CcSEcCtD
Zolmitriptan—Cough—Epirubicin—pancreatic cancer	0.000223	0.000389	CcSEcCtD
Zolmitriptan—Asthenia—Docetaxel—pancreatic cancer	0.000222	0.000387	CcSEcCtD
Zolmitriptan—Convulsion—Epirubicin—pancreatic cancer	0.000222	0.000386	CcSEcCtD
Zolmitriptan—Hypertension—Epirubicin—pancreatic cancer	0.000221	0.000385	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00022	0.000382	CcSEcCtD
Zolmitriptan—Pruritus—Docetaxel—pancreatic cancer	0.000219	0.000381	CcSEcCtD
Zolmitriptan—Myalgia—Epirubicin—pancreatic cancer	0.000218	0.000379	CcSEcCtD
Zolmitriptan—Chest pain—Epirubicin—pancreatic cancer	0.000218	0.000379	CcSEcCtD
Zolmitriptan—Arthralgia—Epirubicin—pancreatic cancer	0.000218	0.000379	CcSEcCtD
Zolmitriptan—Agitation—Doxorubicin—pancreatic cancer	0.000218	0.000379	CcSEcCtD
Zolmitriptan—Anxiety—Epirubicin—pancreatic cancer	0.000217	0.000378	CcSEcCtD
Zolmitriptan—Discomfort—Epirubicin—pancreatic cancer	0.000215	0.000375	CcSEcCtD
Zolmitriptan—Malaise—Doxorubicin—pancreatic cancer	0.000214	0.000372	CcSEcCtD
Zolmitriptan—Dry mouth—Epirubicin—pancreatic cancer	0.000213	0.000371	CcSEcCtD
Zolmitriptan—Vertigo—Doxorubicin—pancreatic cancer	0.000213	0.00037	CcSEcCtD
Zolmitriptan—Syncope—Doxorubicin—pancreatic cancer	0.000212	0.00037	CcSEcCtD
Zolmitriptan—Leukopenia—Doxorubicin—pancreatic cancer	0.000212	0.000369	CcSEcCtD
Zolmitriptan—Diarrhoea—Docetaxel—pancreatic cancer	0.000212	0.000369	CcSEcCtD
Zolmitriptan—Confusional state—Epirubicin—pancreatic cancer	0.000211	0.000367	CcSEcCtD
Zolmitriptan—Palpitations—Doxorubicin—pancreatic cancer	0.000209	0.000364	CcSEcCtD
Zolmitriptan—Oedema—Epirubicin—pancreatic cancer	0.000209	0.000364	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000209	0.000364	CcSEcCtD
Zolmitriptan—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000208	0.000362	CcSEcCtD
Zolmitriptan—Infection—Epirubicin—pancreatic cancer	0.000208	0.000361	CcSEcCtD
Zolmitriptan—Cough—Doxorubicin—pancreatic cancer	0.000207	0.00036	CcSEcCtD
Zolmitriptan—Shock—Epirubicin—pancreatic cancer	0.000206	0.000358	CcSEcCtD
Zolmitriptan—Convulsion—Doxorubicin—pancreatic cancer	0.000205	0.000357	CcSEcCtD
Zolmitriptan—Nervous system disorder—Epirubicin—pancreatic cancer	0.000205	0.000356	CcSEcCtD
Zolmitriptan—Dizziness—Docetaxel—pancreatic cancer	0.000205	0.000356	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000205	0.000356	CcSEcCtD
Zolmitriptan—Hypertension—Doxorubicin—pancreatic cancer	0.000205	0.000356	CcSEcCtD
Zolmitriptan—Tachycardia—Epirubicin—pancreatic cancer	0.000204	0.000355	CcSEcCtD
Zolmitriptan—Skin disorder—Epirubicin—pancreatic cancer	0.000203	0.000353	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000202	0.000351	CcSEcCtD
Zolmitriptan—Arthralgia—Doxorubicin—pancreatic cancer	0.000202	0.000351	CcSEcCtD
Zolmitriptan—Myalgia—Doxorubicin—pancreatic cancer	0.000202	0.000351	CcSEcCtD
Zolmitriptan—Chest pain—Doxorubicin—pancreatic cancer	0.000202	0.000351	CcSEcCtD
Zolmitriptan—Anxiety—Doxorubicin—pancreatic cancer	0.000201	0.00035	CcSEcCtD
Zolmitriptan—Discomfort—Doxorubicin—pancreatic cancer	0.000199	0.000347	CcSEcCtD
Zolmitriptan—Anorexia—Epirubicin—pancreatic cancer	0.000199	0.000346	CcSEcCtD
Zolmitriptan—Dry mouth—Doxorubicin—pancreatic cancer	0.000197	0.000343	CcSEcCtD
Zolmitriptan—Vomiting—Docetaxel—pancreatic cancer	0.000197	0.000343	CcSEcCtD
Zolmitriptan—Rash—Docetaxel—pancreatic cancer	0.000195	0.00034	CcSEcCtD
Zolmitriptan—Dermatitis—Docetaxel—pancreatic cancer	0.000195	0.000339	CcSEcCtD
Zolmitriptan—Confusional state—Doxorubicin—pancreatic cancer	0.000195	0.000339	CcSEcCtD
Zolmitriptan—Headache—Docetaxel—pancreatic cancer	0.000194	0.000338	CcSEcCtD
Zolmitriptan—Oedema—Doxorubicin—pancreatic cancer	0.000193	0.000336	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000193	0.000336	CcSEcCtD
Zolmitriptan—Infection—Doxorubicin—pancreatic cancer	0.000192	0.000334	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00019	0.000331	CcSEcCtD
Zolmitriptan—Shock—Doxorubicin—pancreatic cancer	0.00019	0.000331	CcSEcCtD
Zolmitriptan—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00019	0.00033	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000189	0.000329	CcSEcCtD
Zolmitriptan—Insomnia—Epirubicin—pancreatic cancer	0.000189	0.000329	CcSEcCtD
Zolmitriptan—Tachycardia—Doxorubicin—pancreatic cancer	0.000189	0.000328	CcSEcCtD
Zolmitriptan—Skin disorder—Doxorubicin—pancreatic cancer	0.000188	0.000327	CcSEcCtD
Zolmitriptan—Paraesthesia—Epirubicin—pancreatic cancer	0.000188	0.000326	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000187	0.000325	CcSEcCtD
Zolmitriptan—Dyspnoea—Epirubicin—pancreatic cancer	0.000186	0.000324	CcSEcCtD
Zolmitriptan—Somnolence—Epirubicin—pancreatic cancer	0.000186	0.000323	CcSEcCtD
Zolmitriptan—Anorexia—Doxorubicin—pancreatic cancer	0.000184	0.000321	CcSEcCtD
Zolmitriptan—Nausea—Docetaxel—pancreatic cancer	0.000184	0.00032	CcSEcCtD
Zolmitriptan—Dyspepsia—Epirubicin—pancreatic cancer	0.000184	0.00032	CcSEcCtD
Zolmitriptan—Decreased appetite—Epirubicin—pancreatic cancer	0.000182	0.000316	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00018	0.000314	CcSEcCtD
Zolmitriptan—Constipation—Epirubicin—pancreatic cancer	0.000179	0.000311	CcSEcCtD
Zolmitriptan—Pain—Epirubicin—pancreatic cancer	0.000179	0.000311	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000176	0.000306	CcSEcCtD
Zolmitriptan—Insomnia—Doxorubicin—pancreatic cancer	0.000175	0.000304	CcSEcCtD
Zolmitriptan—Paraesthesia—Doxorubicin—pancreatic cancer	0.000174	0.000302	CcSEcCtD
Zolmitriptan—Dyspnoea—Doxorubicin—pancreatic cancer	0.000172	0.0003	CcSEcCtD
Zolmitriptan—Feeling abnormal—Epirubicin—pancreatic cancer	0.000172	0.0003	CcSEcCtD
Zolmitriptan—Somnolence—Doxorubicin—pancreatic cancer	0.000172	0.000299	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000171	0.000297	CcSEcCtD
Zolmitriptan—Dyspepsia—Doxorubicin—pancreatic cancer	0.00017	0.000296	CcSEcCtD
Zolmitriptan—Decreased appetite—Doxorubicin—pancreatic cancer	0.000168	0.000292	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000167	0.00029	CcSEcCtD
Zolmitriptan—Urticaria—Epirubicin—pancreatic cancer	0.000166	0.000289	CcSEcCtD
Zolmitriptan—Pain—Doxorubicin—pancreatic cancer	0.000165	0.000288	CcSEcCtD
Zolmitriptan—Constipation—Doxorubicin—pancreatic cancer	0.000165	0.000288	CcSEcCtD
Zolmitriptan—Abdominal pain—Epirubicin—pancreatic cancer	0.000165	0.000287	CcSEcCtD
Zolmitriptan—Body temperature increased—Epirubicin—pancreatic cancer	0.000165	0.000287	CcSEcCtD
Zolmitriptan—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000159	0.000277	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000158	0.000275	CcSEcCtD
Zolmitriptan—Hypersensitivity—Epirubicin—pancreatic cancer	0.000154	0.000268	CcSEcCtD
Zolmitriptan—Urticaria—Doxorubicin—pancreatic cancer	0.000154	0.000267	CcSEcCtD
Zolmitriptan—Abdominal pain—Doxorubicin—pancreatic cancer	0.000153	0.000266	CcSEcCtD
Zolmitriptan—Body temperature increased—Doxorubicin—pancreatic cancer	0.000153	0.000266	CcSEcCtD
Zolmitriptan—Asthenia—Epirubicin—pancreatic cancer	0.00015	0.000261	CcSEcCtD
Zolmitriptan—Pruritus—Epirubicin—pancreatic cancer	0.000148	0.000257	CcSEcCtD
Zolmitriptan—Diarrhoea—Epirubicin—pancreatic cancer	0.000143	0.000249	CcSEcCtD
Zolmitriptan—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000142	0.000248	CcSEcCtD
Zolmitriptan—Asthenia—Doxorubicin—pancreatic cancer	0.000139	0.000241	CcSEcCtD
Zolmitriptan—Dizziness—Epirubicin—pancreatic cancer	0.000138	0.00024	CcSEcCtD
Zolmitriptan—Pruritus—Doxorubicin—pancreatic cancer	0.000137	0.000238	CcSEcCtD
Zolmitriptan—Vomiting—Epirubicin—pancreatic cancer	0.000133	0.000231	CcSEcCtD
Zolmitriptan—Diarrhoea—Doxorubicin—pancreatic cancer	0.000132	0.00023	CcSEcCtD
Zolmitriptan—Rash—Epirubicin—pancreatic cancer	0.000132	0.000229	CcSEcCtD
Zolmitriptan—Dermatitis—Epirubicin—pancreatic cancer	0.000132	0.000229	CcSEcCtD
Zolmitriptan—Headache—Epirubicin—pancreatic cancer	0.000131	0.000228	CcSEcCtD
Zolmitriptan—Dizziness—Doxorubicin—pancreatic cancer	0.000128	0.000222	CcSEcCtD
Zolmitriptan—Nausea—Epirubicin—pancreatic cancer	0.000124	0.000216	CcSEcCtD
Zolmitriptan—Vomiting—Doxorubicin—pancreatic cancer	0.000123	0.000214	CcSEcCtD
Zolmitriptan—Rash—Doxorubicin—pancreatic cancer	0.000122	0.000212	CcSEcCtD
Zolmitriptan—Dermatitis—Doxorubicin—pancreatic cancer	0.000122	0.000212	CcSEcCtD
Zolmitriptan—Headache—Doxorubicin—pancreatic cancer	0.000121	0.000211	CcSEcCtD
Zolmitriptan—Nausea—Doxorubicin—pancreatic cancer	0.000115	0.0002	CcSEcCtD
Zolmitriptan—HTR1A—Signaling Pathways—CCK—pancreatic cancer	7.84e-05	0.000419	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TERT—pancreatic cancer	7.82e-05	0.000418	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SST—pancreatic cancer	7.79e-05	0.000417	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—JAG1—pancreatic cancer	7.79e-05	0.000416	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CD44—pancreatic cancer	7.77e-05	0.000415	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOTCH3—pancreatic cancer	7.76e-05	0.000415	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CG—pancreatic cancer	7.69e-05	0.000411	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CNR2—pancreatic cancer	7.64e-05	0.000408	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GLP1R—pancreatic cancer	7.64e-05	0.000408	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CXCL8—pancreatic cancer	7.63e-05	0.000408	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—JAG1—pancreatic cancer	7.63e-05	0.000408	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOTCH3—pancreatic cancer	7.6e-05	0.000406	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—HRAS—pancreatic cancer	7.59e-05	0.000405	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCKAR—pancreatic cancer	7.51e-05	0.000402	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HIF1A—pancreatic cancer	7.48e-05	0.0004	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TSC2—pancreatic cancer	7.46e-05	0.000399	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GCG—pancreatic cancer	7.45e-05	0.000398	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CNR1—pancreatic cancer	7.35e-05	0.000393	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—APOE—pancreatic cancer	7.3e-05	0.00039	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JAG2—pancreatic cancer	7.28e-05	0.000389	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CNR1—pancreatic cancer	7.19e-05	0.000385	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MEN1—pancreatic cancer	7.18e-05	0.000384	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KDR—pancreatic cancer	7.15e-05	0.000382	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CG—pancreatic cancer	7.13e-05	0.000381	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GCG—pancreatic cancer	7.1e-05	0.000379	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—STK11—pancreatic cancer	7e-05	0.000374	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CG—pancreatic cancer	6.98e-05	0.000373	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GCG—pancreatic cancer	6.95e-05	0.000371	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CD—pancreatic cancer	6.9e-05	0.000369	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SHH—pancreatic cancer	6.85e-05	0.000366	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH4—pancreatic cancer	6.81e-05	0.000364	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NFKBIA—pancreatic cancer	6.8e-05	0.000364	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AGTR1—pancreatic cancer	6.77e-05	0.000362	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IAPP—pancreatic cancer	6.76e-05	0.000362	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	6.76e-05	0.000361	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NOTCH1—pancreatic cancer	6.74e-05	0.00036	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—STK11—pancreatic cancer	6.67e-05	0.000357	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AGTR1—pancreatic cancer	6.63e-05	0.000354	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CG—pancreatic cancer	6.59e-05	0.000352	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—NRAS—pancreatic cancer	6.59e-05	0.000352	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—STK11—pancreatic cancer	6.53e-05	0.000349	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EGF—pancreatic cancer	6.51e-05	0.000348	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTHLH—pancreatic cancer	6.49e-05	0.000347	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTCH1—pancreatic cancer	6.49e-05	0.000347	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PRSS1—pancreatic cancer	6.49e-05	0.000347	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CD—pancreatic cancer	6.27e-05	0.000335	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CD—pancreatic cancer	6.14e-05	0.000328	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—TYMS—pancreatic cancer	6.02e-05	0.000322	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.02e-05	0.000322	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—EGFR—pancreatic cancer	6e-05	0.000321	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SST—pancreatic cancer	5.94e-05	0.000317	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	5.89e-05	0.000315	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.86e-05	0.000313	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SMAD4—pancreatic cancer	5.84e-05	0.000312	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JAG1—pancreatic cancer	5.81e-05	0.000311	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CD—pancreatic cancer	5.79e-05	0.00031	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH3—pancreatic cancer	5.79e-05	0.000309	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCL8—pancreatic cancer	5.78e-05	0.000309	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.74e-05	0.000307	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SMAD4—pancreatic cancer	5.72e-05	0.000306	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HES1—pancreatic cancer	5.71e-05	0.000305	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—KRAS—pancreatic cancer	5.67e-05	0.000303	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCL8—pancreatic cancer	5.66e-05	0.000303	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ARG2—pancreatic cancer	5.62e-05	0.000301	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HES1—pancreatic cancer	5.59e-05	0.000299	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CNR1—pancreatic cancer	5.48e-05	0.000293	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CB—pancreatic cancer	5.46e-05	0.000292	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CB—pancreatic cancer	5.35e-05	0.000286	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CG—pancreatic cancer	5.32e-05	0.000284	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GCG—pancreatic cancer	5.29e-05	0.000283	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCL8—pancreatic cancer	5.25e-05	0.000281	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—PIK3CA—pancreatic cancer	5.21e-05	0.000278	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.15e-05	0.000275	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCL8—pancreatic cancer	5.14e-05	0.000275	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AGTR1—pancreatic cancer	5.05e-05	0.00027	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CB—pancreatic cancer	5.05e-05	0.00027	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TERT—pancreatic cancer	5e-05	0.000267	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—STK11—pancreatic cancer	4.98e-05	0.000266	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TYMP—pancreatic cancer	4.92e-05	0.000263	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—APOE—pancreatic cancer	4.9e-05	0.000262	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TERT—pancreatic cancer	4.89e-05	0.000262	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCL8—pancreatic cancer	4.85e-05	0.000259	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—HRAS—pancreatic cancer	4.82e-05	0.000258	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HIF1A—pancreatic cancer	4.78e-05	0.000256	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TSC2—pancreatic cancer	4.77e-05	0.000255	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AKT1—pancreatic cancer	4.69e-05	0.00025	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HIF1A—pancreatic cancer	4.68e-05	0.00025	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CD—pancreatic cancer	4.68e-05	0.00025	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TSC2—pancreatic cancer	4.67e-05	0.00025	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOE—pancreatic cancer	4.67e-05	0.000249	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CASP3—pancreatic cancer	4.64e-05	0.000248	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KDR—pancreatic cancer	4.57e-05	0.000244	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOE—pancreatic cancer	4.57e-05	0.000244	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCND1—pancreatic cancer	4.52e-05	0.000242	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.49e-05	0.00024	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KDR—pancreatic cancer	4.48e-05	0.000239	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CTNNB1—pancreatic cancer	4.47e-05	0.000239	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CG—pancreatic cancer	4.42e-05	0.000236	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MMP9—pancreatic cancer	4.39e-05	0.000234	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PTEN—pancreatic cancer	4.36e-05	0.000233	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SMAD4—pancreatic cancer	4.36e-05	0.000233	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NFKBIA—pancreatic cancer	4.35e-05	0.000232	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL8—pancreatic cancer	4.31e-05	0.000231	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOTCH1—pancreatic cancer	4.31e-05	0.00023	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARG—pancreatic cancer	4.27e-05	0.000228	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NFKBIA—pancreatic cancer	4.26e-05	0.000228	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HES1—pancreatic cancer	4.26e-05	0.000227	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT1—pancreatic cancer	4.25e-05	0.000227	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOTCH1—pancreatic cancer	4.22e-05	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CG—pancreatic cancer	4.21e-05	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—NRAS—pancreatic cancer	4.21e-05	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGF—pancreatic cancer	4.16e-05	0.000223	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CG—pancreatic cancer	4.12e-05	0.00022	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—NRAS—pancreatic cancer	4.12e-05	0.00022	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGF—pancreatic cancer	4.08e-05	0.000218	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CB—pancreatic cancer	4.08e-05	0.000218	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.06e-05	0.000217	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SRC—pancreatic cancer	4.04e-05	0.000216	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GLP1R—pancreatic cancer	3.96e-05	0.000212	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—pancreatic cancer	3.94e-05	0.000211	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL8—pancreatic cancer	3.92e-05	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—STAT3—pancreatic cancer	3.9e-05	0.000208	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—DPYD—pancreatic cancer	3.9e-05	0.000208	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NRAS—pancreatic cancer	3.89e-05	0.000208	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CD—pancreatic cancer	3.89e-05	0.000208	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—EGFR—pancreatic cancer	3.84e-05	0.000205	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—EGFR—pancreatic cancer	3.76e-05	0.000201	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TERT—pancreatic cancer	3.73e-05	0.000199	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CD—pancreatic cancer	3.7e-05	0.000198	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	3.7e-05	0.000198	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.67e-05	0.000196	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.66e-05	0.000196	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CD—pancreatic cancer	3.63e-05	0.000194	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—KRAS—pancreatic cancer	3.63e-05	0.000194	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MYC—pancreatic cancer	3.62e-05	0.000194	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TGFB1—pancreatic cancer	3.62e-05	0.000193	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.59e-05	0.000192	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HIF1A—pancreatic cancer	3.57e-05	0.000191	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TSC2—pancreatic cancer	3.56e-05	0.00019	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—KRAS—pancreatic cancer	3.55e-05	0.00019	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EGFR—pancreatic cancer	3.54e-05	0.000189	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.53e-05	0.000189	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOE—pancreatic cancer	3.48e-05	0.000186	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KDR—pancreatic cancer	3.41e-05	0.000182	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CB—pancreatic cancer	3.39e-05	0.000181	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—pancreatic cancer	3.36e-05	0.000179	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KRAS—pancreatic cancer	3.35e-05	0.000179	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CA—pancreatic cancer	3.33e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CA—pancreatic cancer	3.26e-05	0.000174	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NFKBIA—pancreatic cancer	3.24e-05	0.000173	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CB—pancreatic cancer	3.23e-05	0.000173	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.22e-05	0.000172	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH1—pancreatic cancer	3.21e-05	0.000172	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CB—pancreatic cancer	3.16e-05	0.000169	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CG—pancreatic cancer	3.14e-05	0.000168	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—NRAS—pancreatic cancer	3.14e-05	0.000168	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGF—pancreatic cancer	3.11e-05	0.000166	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL8—pancreatic cancer	3.1e-05	0.000166	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—HRAS—pancreatic cancer	3.08e-05	0.000165	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CA—pancreatic cancer	3.08e-05	0.000164	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL8—pancreatic cancer	3.04e-05	0.000162	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—HRAS—pancreatic cancer	3.02e-05	0.000161	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT1—pancreatic cancer	3e-05	0.00016	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—pancreatic cancer	2.98e-05	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CASP3—pancreatic cancer	2.97e-05	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT1—pancreatic cancer	2.93e-05	0.000157	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTEN—pancreatic cancer	2.93e-05	0.000156	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CASP3—pancreatic cancer	2.91e-05	0.000155	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCND1—pancreatic cancer	2.89e-05	0.000154	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CD44—pancreatic cancer	2.86e-05	0.000153	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—EGFR—pancreatic cancer	2.86e-05	0.000153	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CTNNB1—pancreatic cancer	2.86e-05	0.000153	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HRAS—pancreatic cancer	2.85e-05	0.000152	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCND1—pancreatic cancer	2.83e-05	0.000151	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP9—pancreatic cancer	2.81e-05	0.00015	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.8e-05	0.00015	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CTNNB1—pancreatic cancer	2.8e-05	0.00015	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTEN—pancreatic cancer	2.79e-05	0.000149	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.78e-05	0.000149	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CD—pancreatic cancer	2.76e-05	0.000148	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP9—pancreatic cancer	2.75e-05	0.000147	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GCG—pancreatic cancer	2.75e-05	0.000147	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.74e-05	0.000146	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTEN—pancreatic cancer	2.73e-05	0.000146	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT1—pancreatic cancer	2.72e-05	0.000145	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—KRAS—pancreatic cancer	2.7e-05	0.000145	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT1—pancreatic cancer	2.66e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SRC—pancreatic cancer	2.59e-05	0.000138	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—STK11—pancreatic cancer	2.58e-05	0.000138	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SRC—pancreatic cancer	2.53e-05	0.000135	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—pancreatic cancer	2.52e-05	0.000135	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT1—pancreatic cancer	2.51e-05	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—STAT3—pancreatic cancer	2.49e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NRAS—pancreatic cancer	2.49e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.48e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—pancreatic cancer	2.47e-05	0.000132	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—STAT3—pancreatic cancer	2.44e-05	0.000131	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NRAS—pancreatic cancer	2.44e-05	0.00013	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.42e-05	0.00013	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	2.41e-05	0.000129	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MYC—pancreatic cancer	2.32e-05	0.000124	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	2.31e-05	0.000124	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TGFB1—pancreatic cancer	2.31e-05	0.000124	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	2.3e-05	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MYC—pancreatic cancer	2.27e-05	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGFR—pancreatic cancer	2.27e-05	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TGFB1—pancreatic cancer	2.26e-05	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	2.23e-05	0.000119	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.22e-05	0.000119	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGFR—pancreatic cancer	2.22e-05	0.000119	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	2.21e-05	0.000118	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	2.16e-05	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KRAS—pancreatic cancer	2.14e-05	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	2.13e-05	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KRAS—pancreatic cancer	2.1e-05	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	2.09e-05	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	2.08e-05	0.000111	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CA—pancreatic cancer	2.06e-05	0.00011	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	2.03e-05	0.000108	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CA—pancreatic cancer	1.97e-05	0.000105	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SRC—pancreatic cancer	1.93e-05	0.000103	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CA—pancreatic cancer	1.93e-05	0.000103	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—pancreatic cancer	1.9e-05	0.000102	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	1.88e-05	0.0001	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—pancreatic cancer	1.86e-05	9.96e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	1.86e-05	9.95e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	1.86e-05	9.92e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	1.82e-05	9.73e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOE—pancreatic cancer	1.81e-05	9.66e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	1.78e-05	9.53e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MYC—pancreatic cancer	1.73e-05	9.24e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	1.72e-05	9.22e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.71e-05	9.14e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	1.69e-05	9.04e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKT1—pancreatic cancer	1.69e-05	9.02e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.63e-05	8.71e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	1.61e-05	8.59e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	1.6e-05	8.54e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	1.57e-05	8.41e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.57e-05	8.41e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.47e-05	7.85e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.43e-05	7.66e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—pancreatic cancer	1.42e-05	7.59e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	1.36e-05	7.26e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.25e-05	6.68e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.24e-05	6.62e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	1.2e-05	6.41e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.08e-05	5.77e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	7.61e-06	4.07e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKT1—pancreatic cancer	6.22e-06	3.33e-05	CbGpPWpGaD
